Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Watala

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Medical Hypotheses|October 1, 1991
May the alterations in lipid fluidity-mediated platelet hypersensitivity contribute to accelerated aging of platelets in diabetes mellitus?C Watala
The International Journal of Biochemistry|November 1, 1992
Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patientsC Watala
Chemico-Biological Interactions|April 15, 1992
Melittin-induced alterations in dynamic properties of human red blood cell membranesC Watala, K Gwoździński
Diabetes Research and Clinical Practice|August 11, 2000
The role of platelets in diabetes-related vascular complicationsA B Sobol, C Watala
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1990
Hemolytic potency and phospholipase activity of some bee and wasp venomsC Watala, J K Kowalczyk
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1992
The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjectsC Watala, P D Winocour
The International Journal of Biochemistry|August 1, 1992
Direct evidence for the alterations in protein structure and conformation upon in vitro nonenzymatic glycosylationC Watala, K Gwozdzinski, M Malek
Thrombosis Research|October 24, 2001
Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombinM A Boncler, M Koziolkiewicz, C Watala
International Journal of Experimental Pathology|October 1, 1992
The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitusC Watala, H Witas, L Olszowska, et al.
Platelets|June 28, 2006
Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?C Watala, M Boncler, T Pietrucha, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Medical Hypotheses|October 1, 1991
May the alterations in lipid fluidity-mediated platelet hypersensitivity contribute to accelerated aging of platelets in diabetes mellitus?C Watala
The International Journal of Biochemistry|November 1, 1992
Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patientsC Watala
Chemico-Biological Interactions|April 15, 1992
Melittin-induced alterations in dynamic properties of human red blood cell membranesC Watala, K Gwoździński
Diabetes Research and Clinical Practice|August 11, 2000
The role of platelets in diabetes-related vascular complicationsA B Sobol, C Watala
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1990
Hemolytic potency and phospholipase activity of some bee and wasp venomsC Watala, J K Kowalczyk
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1992
The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjectsC Watala, P D Winocour
The International Journal of Biochemistry|August 1, 1992
Direct evidence for the alterations in protein structure and conformation upon in vitro nonenzymatic glycosylationC Watala, K Gwozdzinski, M Malek
Thrombosis Research|October 24, 2001
Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombinM A Boncler, M Koziolkiewicz, C Watala
International Journal of Experimental Pathology|October 1, 1992
The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitusC Watala, H Witas, L Olszowska, et al.
Platelets|June 28, 2006
Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?C Watala, M Boncler, T Pietrucha, et al.
Pageof 4